Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Laninamivir. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111018901A reveals a novel synthetic route for Zanamivir and Laninamivir intermediates, offering enhanced purity and cost-effective manufacturing solutions.